Optimum Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,400
Closed -$338K 1050
2019
Q3
$338K Buy
3,400
+2,900
+580% +$276K 0.11% 194
2019
Q2
$46K Sell
500
-475
-49% -$45.1K 0.01% 524
2019
Q1
$92K Sell
975
-100
-9% -$8.75K 0.03% 395
2018
Q4
$69K Sell
1,075
-400
-27% -$29.5K 0.02% 411
2018
Q3
$132K Buy
1,475
+140
+10% +$12.4K 0.04% 363
2018
Q2
$106K Sell
1,335
-660
-33% -$54.8K 0.03% 395
2018
Q1
$178K Buy
+1,995
New +$192K 0.05% 307
2015
Q1
$62K Hold
540
0.02% 467
2014
Q4
$60K Hold
540
0.02% 461
2014
Q3
$54K Hold
540
0.02% 466
2014
Q2
$46K Buy
540
+200
+59% +$15.2K 0.01% 506
2014
Q1
$24K Hold
340
0.01% 491
2013
Q4
$29K Hold
340
0.01% 461
2013
Q3
$26K Buy
+340
New +$23.8K 0.01% 457

Other funds holding CELG

Optimum Investment Advisors's CELG Position: Q4 2019 in Review

Optimum Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,400 shares — an estimated $338K sold.

Optimum Investment Advisors first reported a position in CELG in Q3 2013 and held it in 14 quarters. The position peaked at $338K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Optimum Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Optimum Investment Advisors sold 3,400 Celgene Corp shares in Q4 2019, an estimated $338K.
  • Optimum Investment Advisors first reported a position in Celgene Corp in Q3 2013 and held it in 14 quarters.
  • Optimum Investment Advisors's Celgene Corp position peaked at $338K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Optimum Investment Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.